CN Stock MarketDetailed Quotes

Tellgen Corporation (300642)

Watchlist
  • 15.10
  • -0.45-2.89%
Market Closed May 21 15:00 CST
2.45BMarket Cap-1006.67P/E (TTM)

Tellgen Corporation (300642) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
In vitro diagnostic reagent346.51M95.24%
In vitro diagnostic instrument12.33M3.39%
Service income4.9M1.35%
Other99.17K0.03%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
In vitro diagnosis industry363.83M100.00%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
China-East China161.36M44.35%
Domestic North China52.66M14.47%
China-South China41.41M11.38%
Internal-south-west41.17M11.32%
China-Central China26.66M7.33%
Domestic-North-East16.63M4.57%
Domestic-Northwest15.24M4.19%
Abroad8.69M2.39%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
According to Saudi sources, the United States and Iran will hold a new round of talks in Islamabad, the capital of Pakistan, after the end o Show More